Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
OSIRIS THERAPEUTICS, INC. (0001360886)
Standardized SEC financial data for OSIRIS THERAPEUTICS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001360886 · Biological Products, (No Diagnostic Substances).
Gross margin
73.3%
Operating margin
6.9%
Net margin
25.8%
Revenue growth (YoY)
20.5%
Return on equity
47.0%
Free cash flow
$7.1M
Current ratio
3.41×
EPS (diluted)
$1.07
Ratios for fiscal year 2018, standardized from SEC filings.